2026 Recipients
Sriram Vaidyanathan
Sriram Vaidyanathan | Biomedical Engineering
Principal Investigator, Nationwide Children's Hospital, Assistant Professor, Pediatrics, The Ohio State University
Sriram Vaidyanathan’s work is advancing the field of regenerative medicine and has the potential to substantially improve health outcomes for patients with currently untreatable conditions. In 2022, he accepted a joint appointment at Nationwide Children’s Hospital as a principal investigator and The Ohio University as an assistant professor.
His primary innovation lies in gene editing and stem cell therapy to treat cystic fibrosis, a devastating genetic disorder that is fatal in childhood if left untreated. Genome editing offers a durable cure but is limited by the inability to precisely correct the genetic mutation in vivo in long-lived stem cells that regenerate the lung. In response, he has leveraged CRISPR/Cas9 technology to pioneer techniques that enable precise insertion of long genes in airway stem cells, paving the way for a durable treatment. Efforts to scale up and test CRISPR/Cas9 methods are in progress and may include future applications to treat other airway disorders.
His research on this technology commenced when he was a post-doctoral scholar at Stanford University, where he led a multi-disciplinary collaboration. His work received multiple recognitions, including grants from the California Institute of Regenerative Medicine, the prestigious $1 million National Institutes of Health K99/R00 Pathway to Independence Award, and a fellowship from the Cystic Fibrosis Foundation. Vaidyanathan is the inventor on one awarded patent with two additional patents under evaluation. He has co-authored 26 publications that have been cited in 1,400 publications.
“Purdue Engineering instilled a rigorous problem-solving mindset and provided hands-on experiences that reinforced theoretical concepts. The values of innovation, perseverance and collaboration that I gained at Purdue continue to guide my career.”